# Ashland Inc.: overview

ASH · NYSE · CIK 1674862 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/ash.md) · [Financials](/companies/ash/financials.md) · [Filings](/companies/ash/filings.md) · [Insiders](/companies/ash/insiders.md)

Latest reported revenue: [$497.0m](/filings/0001193125-26-324226.md) for Q3 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-324226).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [522 d](/filings/0001193125-25-289248.md) | [405](/filings/0001193125-26-035054.md) | [479](/filings/0001193125-26-191380.md) | [463](/filings/0001193125-26-324226.md) | [477 d](/filings/0001193125-25-289248.md) | [386](/filings/0001193125-26-035054.md) | [482](/filings/0001193125-26-191380.md) | [497](/filings/0001193125-26-324226.md) |
| Gross margin | % | [33.3% d](/filings/0001193125-25-289248.md) | [27.4%](/filings/0001193125-26-035054.md) | [30.7%](/filings/0001193125-26-191380.md) | [28.5%](/filings/0001193125-26-324226.md) | [33.3% d](/filings/0001193125-25-289248.md) | [27.2%](/filings/0001193125-26-035054.md) | [30.5%](/filings/0001193125-26-191380.md) | [34.2%](/filings/0001193125-26-324226.md) |
| Operating margin | % | [5.9% d](/filings/0001193125-25-289248.md) | [(44.2%)](/filings/0001193125-26-035054.md) | [10.6%](/filings/0001193125-26-191380.md) | [(152.9%)](/filings/0001193125-26-324226.md) | [12.8% d](/filings/0001193125-25-289248.md) | [(1.6%)](/filings/0001193125-26-035054.md) | [8.1%](/filings/0001193125-26-191380.md) | [8.7%](/filings/0001193125-26-324226.md) |
| Net margin | % | [3.1% d](/filings/0001193125-25-289248.md) | [(40.7%)](/filings/0001193125-26-035054.md) | [6.5%](/filings/0001193125-26-191380.md) | [(160.3%)](/filings/0001193125-26-324226.md) | [6.7% d](/filings/0001193125-25-289248.md) | [(3.1%)](/filings/0001193125-26-035054.md) | [3.3%](/filings/0001193125-26-191380.md) | [3.2%](/filings/0001193125-26-324226.md) |
| Diluted EPS | $ per share | not reported | [(3.50)](/filings/0001193125-26-035054.md) | [0.65](/filings/0001193125-26-191380.md) | [(16.21)](/filings/0001193125-26-324226.md) | not reported | [(0.26)](/filings/0001193125-26-035054.md) | [0.34](/filings/0001193125-26-191380.md) | [0.35](/filings/0001193125-26-324226.md) |
| Free cash flow | $m | [42.0 d](/filings/0001193125-25-289248.md) | [(53.0)](/filings/0001193125-26-035054.md) | [(12.0) d](/filings/0001193125-26-191380.md) | [95.0 d](/filings/0001193125-26-324226.md) | [6.0 d](/filings/0001193125-25-289248.md) | [111](/filings/0001193125-26-035054.md) | [33.0 d](/filings/0001193125-26-191380.md) | [100 d](/filings/0001193125-26-324226.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,111](/filings/0000950170-23-064715.md) | [2,391](/filings/0000950170-24-128009.md) | [2,191](/filings/0001193125-25-289248.md) | [2,113](/filings/0001193125-25-289248.md) | [1,824](/filings/0001193125-25-289248.md) |
| Gross margin | % | [31.7%](/filings/0000950170-23-064715.md) | [34.7%](/filings/0000950170-24-128009.md) | [30.5%](/filings/0001193125-25-289248.md) | [29.2%](/filings/0001193125-25-289248.md) | [30.1%](/filings/0001193125-25-289248.md) |
| Operating margin | % | [9.1%](/filings/0000950170-23-064715.md) | [13.9%](/filings/0000950170-24-128009.md) | [7.9%](/filings/0001193125-25-289248.md) | [(1.2%)](/filings/0001193125-25-289248.md) | [(42.5%)](/filings/0001193125-25-289248.md) |
| Net margin | % | [10.4%](/filings/0000950170-23-064715.md) | [38.8%](/filings/0000950170-24-128009.md) | [8.1%](/filings/0001193125-25-289248.md) | [8.0%](/filings/0001193125-25-289248.md) | [(46.3%)](/filings/0001193125-25-289248.md) |
| Diluted EPS | $ per share | [3.59](/filings/0000950170-23-064715.md) | [16.41](/filings/0000950170-24-128009.md) | [3.31](/filings/0001193125-25-289248.md) | [3.36](/filings/0001193125-25-289248.md) | [(18.23)](/filings/0001193125-25-289248.md) |
| Free cash flow | $m | [361](/filings/0000950170-23-064715.md) | [80.0](/filings/0000950170-24-128009.md) | [124](/filings/0001193125-25-289248.md) | [325](/filings/0001193125-25-289248.md) | [36.0](/filings/0001193125-25-289248.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ash/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $376.4m | 5,712,189 |  | Added +1,417,278 |
| [Standard Investments LLC](/funds/1539436.md) | 2026-06-30 | $298.2m | 4,525,001 |  | Added +1,900,001 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $238.3m | 3,616,479 |  | Added +1,874,130 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $163.8m | 2,486,307 |  | Reduced −9,714 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $162.3m | 2,462,838 |  | Added +267,893 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $135.9m | 2,063,055 |  | Added +10,513 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $134.3m | 2,037,663 |  | Reduced −777,224 |
| [FRONTIER CAPITAL MANAGEMENT CO LLC](/funds/351173.md) | 2026-06-30 | $131.8m | 1,999,908 |  | Added +87,219 |
| [Ancora Advisors LLC](/funds/1446114.md) | 2026-06-30 | $128.2m | 1,945,412 |  | Added +1,945,112 |
| [COOPERMAN LEON G](/funds/898382.md) | 2026-06-30 | $124.9m | 1,895,000 |  | Added +195,000 |

## Recent filings

[All 1,078 filings](/companies/ash/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-25 | 16:30 ET | [8-K](/filings/0001193125-26-402900.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-402900 |
| 2026-08-10 | 16:30 ET | [8-K/A](/filings/0001193125-26-342480.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-342480 |
| 2026-07-31 | 16:30 ET | [8-K](/filings/0001193125-26-328710.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-328710 |
| 2026-07-29 | 17:17 ET | [10-Q](/filings/0001193125-26-324226.md) | Quarterly report, period 2026-06-30 | 0001193125-26-324226 |
| 2026-07-28 | 17:12 ET | [8-K](/filings/0001193125-26-321247.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001193125-26-321247 |
| 2026-07-28 | 17:10 ET | [8-K](/filings/0001193125-26-321238.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-321238 |
| 2026-05-29 | 06:30 ET | [8-K](/filings/0001193125-26-246229.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-246229 |
| 2026-05-18 | 16:30 ET | [8-K](/filings/0001193125-26-228980.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-228980 |
| 2026-05-18 | 08:15 ET | [SCHEDULE 13D/A](/filings/0001104659-26-063028.md) | Ownership report, active investor, amended | 0001104659-26-063028 |
| 2026-05-12 | 08:15 ET | [SCHEDULE 13D/A](/filings/0001104659-26-059033.md) | Ownership report, active investor, amended | 0001104659-26-059033 |

## Latest annual report

[Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001193125-25-289248.md), filed Nov 20, 2025.

## Forecast league

Q4 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/3c64bca2-f937-4875-ad9c-7ec92a92ea1d)

## About the filer

- CIK: 1674862
- Tickers: ASH
- Exchange: NYSE
- SIC code: 5160 Wholesale-Chemicals & Allied Products
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:12 ET. No prices; not investment advice.